Christopher E. Mason
Christopher E. Mason | |
|---|---|
April 2019 | |
| Education | University of Wisconsin–Madison (BS), Yale University (PhD) |
| Scientific career | |
| Fields | Biology |
| Workplaces | Weill Cornell Medicine |
Doctoral students | Lenore Pipes |
| Website | https://physiology.med.cornell.edu/people/christopher-mason-ph-d/ |
Christopher E. Mason is a professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine. He is also one of the founding Directors of the WorldQuant Initiative for Quantitative Prediction together with Olivier Elemento. Mason has co-founded four biotechnology startup companies including Onegevity Health, Biotia, BridgeOmics, and Nurture Genomics. He holds four patents related to his research.